The current price of AZTA is $39.16 — it has increased by 4.76% since the previous close. Data as of Nov 6, 2026.
AZTA is down 0.05% over the past week, up 9.11% over the past month and up 33.33% over the past year. The price is above its 200-day moving average of $28.31.
Of the 6 analysts covering Azenta, Inc., 1 rates it a strong buy, 2 rate it a buy and 3 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
Azenta, Inc. has a market capitalization of $1.72B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, Azenta, Inc. posted earnings of $0.16 per share against an estimate of $0.1138, beating expectations by 40.60%. Upcoming reports are listed in the earnings calendar.
Azenta, Inc. reported revenue of $161.18M in its most recent quarter, which has increased by 11.97% compared with the same quarter a year earlier. Analysts had expected $149.31M.
Azenta, Inc. has not paid any dividends over the past year.
Companies most comparable to Azenta, Inc. include Thermo Fisher Scientific Inc., Danaher Corporation, Solventum Corporation, Bio-Techne Corporation and Bio-Rad Laboratories, Inc.
In the latest trading session AZTA moved between $37.23 and $39.34, a range of 5.39% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of Azenta, Inc. shows a strong buy rating today. Technical ratings are indicators, not investment advice.
Over the past 52 weeks AZTA has traded between $15.93 and $46.41. The current price is 15.62% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.